Understand your risk of ovarian cancer

150

English

+ Infographic text

Anyone who has ovaries can develop ovarian cancer.

Prevention is not yet possible, but some factors play an important role in increasing and reducing their risk.

Factors that increase the risk of ovarian cancer

Old

  • Have 55 years or more
    • Most cases of ovarian cancer develop after menopause.

Gynecological factors

  • First full pregnancy after the age of 35
  • Have no full pregnancy
  • Late menopause
  • Early start of menstrual periods
  • Endometriosis
  • infertility

Hormone therapy after menopause

  • Estrogen treatment without progesterone

genetics

  • Family history of ovary, chest or colon cancer
  • Have a genetic mutation of ovarian, breast or colon cancer
    • BRCA1, BRCA2 or Lynch syndrome
      • Up to 1 of 4 ovarian cancer are the product of genetic mutations

An earlier diagnosis of breast cancer

obesity

Factors that could increase their risk, but further studies are required

Research results are still carried out, the ovarian cancer risks with:

  • Talc powder
  • Fertility treatments

Factors that reduce their risk of ovarian cancer

Control Natal

  • Contraceptive pills
  • Diu
  • Tubal division

Did you know the following? Some doctors still recommend tube ligatures. Now it is common to remove the fallopian tubes for permanent sterilization.

Gynecological factors

  • Breastfeed
  • Full pregnancy
    • Every full pregnancy is increasingly reducing its risk
  • Early menopause (45 years ago)

Operations

  • Salpingectomía
    • Distance from fallopian ladder, which is often carried out during another operation
  • SalpingOophorectomy bilateral
    • Distance from ovaries and fallopian tubes
  • hysterectomy
    • Removal

Did you know the following? Most cases of ovarian cancer begin with precancator cells on fallopian tubes

Removing the fallopian tubes is low surgery with low risk, which could significantly reduce their risk of ovarian cancer.

This educational resource was created with the support of Daiichi Sankyo and Merck.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More